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The Sigma Receptor as a Ligand-Regulated
Auxiliary Potassium Channel Subunit
sterol isomerase. Initially, hydropathy analysis of the
deduced amino acid sequence suggested a single trans-
membrane segment. However, the present study pre-
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Bock Laboratories Soriani et al., 1999, 1998; Wilke et al., 1999a, 1999b).
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1525 Linden Drive raises the question of how signals are transmitted to
their channel targets. This question was posed in pitu-Madison, Wisconsin 53706
itary nerve terminals, where sigma receptors inhibit volt-
age-gated K channels (Wilke et al., 1999a). To test
the role of G proteins, nerve terminals were perfusedSummary
internally with GTPS or GDPS (Lupardus et al., 2000).
Responses to sigma receptor ligands were completelyThe sigma receptor is a novel protein that mediates
the modulation of ion channels by psychotropic drugs unaffected, indicating that G proteins do not mediate
these responses. ATP omission and replacement bythrough a unique transduction mechanism depending
neither on G proteins nor protein phosphorylation. The AMPPcP in both whole-terminal and outside-out patch
recordings also failed to diminish the actions of sigmapresent study investigated sigma receptor signal
transduction by reconstituting responses in Xenopus receptor ligands. Thus, protein phosphorylation also
does not play a role. Experiments in cell-free excisedoocytes. Sigma receptors modulated voltage-gated K
channels (Kv1.4 or Kv1.5) in different ways in the pres- patches further ruled out requirements for soluble cyto-
plasmic factors in sigma receptor signal transduction,ence and absence of ligands. Association between Kv1.4
channels and sigma receptors was demonstrated by and experiments in cell-attached patches indicated that
sigma receptors and their target channels must be in thecoimmunoprecipitation. These results indicate a novel
mechanism of signal transduction dependent on pro- same patch of cell membrane. Thus, signal transduction
requires close proximity between the receptor and chan-tein-protein interactions. Domain accessibility experi-
ments suggested a structure for the sigma receptor nel (Lupardus et al., 2000). These studies eliminate the
more familiar mechanisms of ion channel modulationwith two cytoplasmic termini and two membrane-
spanning segments. The ligand-independent effects involving G proteins and phosphorylation. Since these
mechanisms underlie nearly all the known forms of ionon channels suggest that sigma receptors serve as
auxiliary subunits to voltage-gated K channels with channel modulation (Hille, 1992; Jonas and Kaczmarek,
1996; Wickman and Clapham, 1995), these results raisedistinct functional interactions, depending on the
presence or absence of ligand. the question of whether the sigma receptor employs a
novel mechanism of transduction.
To clarify the molecular basis of signal transductionIntroduction
by sigma receptors, we employed the Xenopus laevis
oocyte system to express sigma receptors, togetherThe sigma receptor was first described as a novel opioid
receptor (Martin et al., 1976), but subsequent studies with voltage-gated K channels. The reconstitution of
sigma receptor-mediated responses in a heterologousdemonstrated that it is a distinct pharmacological entity
distinguished by unusually promiscuous binding to a expression system allowed us to approach the question
of transduction at a molecular level. Immunoprecipita-wide variety of ligands (Zukin and Zukin, 1979; Su, 1993;
de Costa and He, 1994). Binding of antipsychotic drugs tion experiments, together with comparisons of physio-
logical properties between oocytes and neurons, estab-(such as haloperidol) and psychomimetic drugs (such
as pentazocine), along with a genetic linkage to schizo- lished that sigma receptors interact with K channels
and that ligand binding to the sigma receptor modulatesphrenia (Ishiguro et al., 1998), implicate sigma receptors
in psychosis. Additional functions of sigma receptors in channel activity through this interaction.
motor, endocrine, and immune systems have also been
suggested (Su, 1993; Walker et al., 1993). A sigma recep- Results
tor photoprobe labels a protein with a molecular weight
of 26 kDa (Kahoun and Ruoho, 1992). The gene encoding Reconstitution of Sigma Receptor Function
the sigma receptor was cloned and the protein shown in Oocytes
to have a similar molecular weight of 25.3 kDa (Hanner In oocytes expressing the voltage-gated K channels
et al., 1996; Kekuda et al., 1996; Seth et al., 1997). This Kv1.4 or Kv1.5, either alone or with sigma receptor,
protein lacks significant homology with known mamma- depolarizing voltage steps evoked large K currents
lian proteins but possesses weak homology with fungal (Figures 1A–1D). In cells coexpressing channels and
sigma receptors, the K currents were highly sensitive
to sigma receptor ligands. By contrast, the modulation3Correspondence: mjackson@physiology.wisc.edu
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Figure 1. Sigma Receptor-Mediated Modu-
lation of K Channels in Oocytes
Currents through K channels formed by
Kv1.4 or Kv1.5 were evoked by 900 ms volt-
age pulses to 50 mV, following a 200 ms con-
ditioning pulse from 80 mV to 120 mV
(pulse sequence shown schematically be-
low). In oocytes expressing only a K chan-
nel, 100 M SKF 10047 slightly reduced out-
ward current in both Kv1.4 (A) and Kv1.5 (B).
In oocytes expressing a K channel and the
sigma receptor, SKF10047 reduced outward
current by more than half in both Kv1.4 (C)
and Kv1.5 (D). In oocytes expressing K chan-
nels and injected with sigma receptor anti-
sense mRNA, SKF10047 produced little, if
any, reduction in outward current in both
Kv1.4 (E) and Kv1.5 (F). In all experiments,
the drug tests were recorded 2 min after add-
ing 100 M SKF10047. Washes were re-
corded 30 min later after perfusing with con-
trol solution.
of recorded current by these ligands was very weak in sence of expressed sigma receptors could be due either
to a direct but weak interaction of the ligand with the twocells expressing only K channels. In 75% of the 18
oocytes expressing only a voltage-gated K channel, K channels we are studying. Alternatively, endogenous
Xenopus sigma receptor expressed in oocytes couldthe sigma receptor ligand SKF10047 failed to produce
a detectible inhibition of outward current elicited by de- mediate the observed effect. To address this question,
we attempted to suppress endogenous sigma receptorpolarizing voltage pulses. In the remaining oocytes, a
small amount of block was seen (Figure 1A). Similar production by injecting sigma receptor antisense RNA,
together with Kv1.4 or Kv1.5 mRNA. Sigma receptorresults were obtained with ditolyl-guanidine (DTG) (data
not shown). In oocytes expressing only Kv1.5, the results ligands failed to modulate K channels to a detectible
degree in all oocytes tested expressing Kv1.4 channelswere similar (Figure 1B). SKF10047 failed to inhibit cur-
rent in 70% of the oocytes expressing only Kv1.5 (n  (Figure 1E). Antisense suppression was also seen in
oocytes expressing Kv1.5 channels, but the suppression20), and in the remaining oocytes, the inhibition was
weak. Coexpression of K channels with sigma recep- was not complete, and a small amount of ligand-induced
channel modulation was seen in 10% of the oocytestors dramatically increased responses to ligands. SKF
10047 blocked K current by 50% in all oocytes ex- tested (Figure 1F). The residual Kv1.5 channel current
inhibition induced by SKF10047 was lower than the inhi-pressing sigma receptors, together with either Kv1.4
(Figure 1C, n  22) or Kv1.5 (Figure 1D, n  24). DTG bition seen without sigma receptor antisense RNA, but
this difference was not statistically significant. However,was equally effective (data not shown). Sigma receptor
ligands inhibited K current by an average of 75% suppression of endogenous sigma receptor reduced re-
sponses to levels not significantly different from zero.when sigma receptor was expressed but by only 12–
25% without sigma receptor (Figure 2). Thus, K chan- Figure 2 summarizes the expression studies for recon-
stitution of sigma receptor-mediated K channel modu-nels show consistent and robust responses to sigma
receptor ligands only when the sigma receptor is coex- lation. The small amount of modulation of Kv1.4 and
Kv1.5 in the absence of exogenous sigma receptor ispressed.
The weak effect of sigma receptor ligands in the ab- similar to that reported by Suessbrich et al. (1997) for
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tors (Wilke et al., 1999a). However, quantitative analysis
revealed a significant difference between the A current
of pituitary nerve terminals and Kv1.4 in oocytes. The A
current in nerve terminals inactivated with a time con-
stant of 21.2  2.1 ms (n  9) at 40 mV. This was nearly
3-fold faster than inactivation of expressed Kv1.4 chan-
nels at the same voltage. However, the inactivation rate
of the pituitary A current was very similar to that seen
for Kv1.4 in oocytes coexpressing high levels of sigma
receptor. This trend was seen for other voltages as well
(Figure 3B). Time constants measured from current de-
cays in oocytes injected with sigma receptor and Kv1.4
mRNA at a 2:1 ratio fell very close to the time constants
taken from the rapid component of current decay in
pituitary nerve terminals. Thus, coexpression of Kv1.4
with sigma receptors produces channels with inactiva-
tion behavior in oocytes that is essentially the same as
Figure 2. Summary of K Channel Modulation that seen in vivo. These experiments demonstrate that
The bars show the mean percent inhibition by 100 M SKF10047 sigma receptors modulate Kv1.4 channels even in the
from the experiments in Figure 1. When only a K channel was
absence of drugs and further suggest that ligand-inde-expressed, current was inhibited by 10%–20%. When a K channel
pendent sigma receptor interactions account for thewas coexpressed with sigma receptor, inhibition was 75%. Ex-
difference between Kv1.4 channel properties in the oo-pression of channels with sigma receptor antisense mRNA reduced
the amount of inhibition to insignificant levels. cyte system and in vivo.
We compared other biophysical properties of Kv1.4
expressed with and without sigma receptors. Plots of
another sigma receptor ligand, haloperidol. In light of current versus voltage showed that coexpression of the
the present findings, it is likely that this result can be sigma receptor reduced the current at all voltages be-
attributed to the low levels of endogenous Xenopus tween 20 and 40 mV (Figure 4A). Normalizing to the
sigma receptor. This interpretation is also consistent maximum current and dividing by the driving force (V 
EK, assuming EK80 mV) yielded plots of conductancewith a previous demonstration of low levels of binding
that allowed us to compare the voltage dependence ofactivity for a sigma receptor ligand in Xenopus oocytes
channel activation (Figure 4B). These plots showed that(Yamamoto et al., 1999).
the presence of the sigma receptor had no effect on the
channel activation curve. V1/2 9.0 3.0 mV for Kv1.4Ligand-Independent Receptor-Channel
alone and 7.9  4.0 mV for Kv1.4  sigma receptorInteractions
(in a ratio of 1:2). The steepness factors were also un-
In addition to the ligand-dependent modulation of ion
changed. In summary, Kv1.4 channels interact with
channels by sigma receptors demonstrated above, we
sigma receptors in the absence of ligand to accelerate
found that sigma receptors altered the functional activity channel inactivation. Net current was also reduced, but
of Kv1.4 channels in the absence of sigma receptor the voltage dependence of channel activation showed
ligands. The channels formed by Kv1.4 inactivate in re- no detectable change.
sponse to sustained depolarization, leading to a reduc-
tion in outward current (Figures 1A, 1C, and 1E). Figure Location and Membrane Topology
3A superimposes a control K current trace (i.e., no of the Sigma Receptor
drug) from an oocyte expressing Kv1.4 alone, with a Various studies have indicated that sigma receptors may
control K current trace from an oocyte expressing be located in the cytoplasm (Hayashi and Su, 2001), on
Kv1.4 and sigma receptor. This figure shows that the the cell surface (Lupardus et al., 2000), or in both places
current through Kv1.4 channels inactivates more rapidly (Morin-Surun et al., 1999). To investigate this issue, we
in the presence of coexpressed sigma receptor. For injected oocytes with mRNA encoding constructs of the
voltage pulses to 40 mV, fitting the inactivating current sigma receptor fused in frame with GFP at either the N or
to a single exponential gave a time constant of 61  7 C terminus. 4 days after injection, confocal fluorescence
ms (n  8) in oocytes expressing Kv1.4 alone, and 47  microscopy revealed bright surface labeling in over 30
4 ms (n  6) in oocytes injected with equal amounts of oocytes. The fluorescence was clearly localized near the
Kv1.4 and sigma receptor mRNA. Increasing the ratio plasma membrane for both N-GFP-Sigma (Figure 5A) and
of sigma receptor mRNA to Kv1.4 mRNA to 2:1 further C-GFP-Sigma (data not shown). A cross-section of fluo-
reduced the time constant for inactivation to 26  3 ms rescence intensity through an oocyte is shown (Figure 5B).
(n  4). The same trend was seen at other voltages The fluorescence observed in the cytoplasm was very low
(Figure 3B). Increasing amounts of sigma receptor accel- and indistinguishable from a control oocyte. As controls,
erated Kv1.4 channel inactivation at all voltages tested. Kv1.4-GFP-injected oocytes showed a similar fluorescent
Kv1.4 is expressed in nerve terminals (Sheng et al., profile to the Sigma-GFP constructs, while GFP ex-
1993), and the rapid inactivation of Kv1.4 channels in pressed in oocytes showed characteristic cytoplasmic
oocytes resembles the rapid inactivation of the A current fluorescence (Figure 5C). Thus, the primary location of
in pituitary nerve terminals (Bielefeldt et al., 1992). Fur- GFP-tagged sigma receptor is very close to the plasma
membrane.thermore, this A current was modulated by sigma recep-
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Figure 3. Inactivation Kinetics of Kv1.4
Comparison of current traces for Kv1.4 with Kv1.4 coexpressed with sigma receptor shows that the sigma receptor accelerated the inactivation
of Kv1.4 channels. Currents were elicited by voltage pulses, as in Figure 1.
(B) Time constants of inactivation obtained from single exponential fits were plotted versus voltage. The slowest inactivation was seen in
oocytes expressing Kv1.4 alone. In oocytes injected with equal quantities of Kv1.4 and sigma receptor mRNA, inactivation was faster. Increasing
the ratio of sigma receptor RNA to Kv1.4 RNA (2:1) accelerated inactivation further. Inactivation time constants were also measured for the
A current in posterior pituitary nerve terminals from the fast component of a double exponential fit. These values are very close to those
obtained from oocytes injected with excess sigma receptor mRNA.
The function of these fusion proteins was tested in beled (Sievert and Ruoho, personal communication).
Thus, fusion with GFP at either the C or N terminusoocytes by coexpression with Kv1.4. Both N-GFP-Sigma
and C-GFP-Sigma were capable of modulating Kv1.4 yields a protein that retains its physiological activity.
In the original cloning studies of the sigma receptor,channels when SKF10047 was applied (Figures 5D–5F).
The magnitude of this inhibition (45%) was greater the sequence was proposed to harbor a single trans-
membrane (TM) domain (Hanner et al., 1996; Kekudathan that produced without expressed sigma receptor
(12%) but less than that produced with wild-type et al., 1996; Seth et al., 1997). We also examined the
sequence using a computer program to identify putativesigma receptor (75%). Furthermore, experiments with
the sigma receptor photoprobe iodo-azidococaine (Ka- TM segments based on homology with a database of
known TM segments (at www.isrec.isb-sib.ch) (Hof-houn and Ruoho, 1992) demonstrated that the N-termi-
nal GFP-sigma receptor fusion can be specifically la- mann and Stoffel, 1993). The search was conducted for
Figure 4. Effect of the Sigma Receptor on Kv1.4 Activation
(A) Current-voltage plots were constructed for peak current using a series of voltage steps with prepulses, as in Figure 1. For Kv1.4 alone,
n  7; for Kv1.4  sigma receptor 1:1, n  8; for Kv1.4  sigma receptor 1:2, n  7. Increasing amounts of sigma receptor depressed K
current at all voltages tested.
(B) Normalized conductance-voltage plots. Current plots from (A) for Kv1.4 alone and Kv1.4  sigma receptor 1:2 were divided by driving
force (V  EK; with EK  80) to obtain conductance and normalized to the maximum conductance. The plots are essentially superimposable.
Fits to the Boltzmann equation gave parameters that were not significantly different (see text).
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Figure 5. Localization of Sigma Receptors Expressed in Xenopus Oocytes
(A and B) Confocal fluorescence micrographs at different focal planes of an oocyte expressing N-GFP-Sigma show cell surface localization.
A micrograph is shown with the plane of focus through the middle of the oocyte. The dashed line through the third oocyte shows the path
along which fluorescence intensity was plotted (in B). (B) This plot shows that most of the fluorescence is on or near the cell surface.
(C) As controls, Kv1.4-GFP and GFP-expressing oocytes were also examined. Kv1.4-GFP gave a fluorescence profile similar to that of the
Sigma-GFP constructs, while GFP showed fluorescence in the cell interior.
(D–F) Voltage-clamp of K current showed that 100 M SKF10047 reversibly reduced current in oocytes expressing N-GFP-Sigma and Kv1.4
(n  10). Similar results were obtained with C-GFP-Sigma (E), and the average percent inhibition is shown in (F). The percent inhibition of
Kv1.4 in oocytes without exogenous sigma receptor is reproduced from Figure 2 to show that the inhibition by the fusion protein is beyond
what can be attributed to endogenous Xenopus sigma receptor.
segments with lengths in the range of 17–35 amino To test these models experimentally and to probe the
orientation of the sigma receptor in the plasma mem-acids. The results are plotted in Figure 6A and show
the original putative TM segment of 20 residues, start- brane of the oocyte, we used anti-GFP antibodies to
assess the accessibility of the GFP tags in sigma recep-ing 80 residues from the N terminus. The plot shows
an additional putative TM domain of 21 amino acids tor fusion constructs. The anti-GFP antibody was de-
tected with anti-mouse IgG antibody conjugated tostarting a few residues from the N terminus. Thus, the
sigma receptor may in fact harbor two TM domains Texas red. All oocytes injected with GFP-sigma receptor
fusion protein mRNA showed strong fluorescence whenrather than one.
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Figure 6. Membrane Topology and Orienta-
tion of the Sigma Receptor
(A) TM homology plot based on the deduced
amino acid sequence of the sigma receptor.
The program TMbase (Hofmann and Stoffel,
1993) (www.isrec.isb-sib.ch) shows two seg-
ments with significant homology to TM seg-
ments in the database. The orientation of the
segments as inside-to-outside or outside-to-
inside does not alter the plot. The putative
TM segment from residues 80–100 was iden-
tified in the original reports of the sigma re-
ceptor sequence (Hanner et al., 1996; Kekuda
et al., 1996; Seth et al., 1997). The present
plot indicates another putative TM segment
in the region from residues 10–30.
(B) Localization of the N- and C-terminal GFP
tags in oocytes expressing N-GFP-Sigma and
C-GFP-Sigma. Oocytes were treated with
Texas red-conjugated anti-GFP antibodies.
Fluorescence micrographs of GFP (green) in
unpermeabilized oocytes show surface local-
ization similar to that in Figure 5A. Fluores-
cence micrographs of Texas red-conjugated
anti-GFP antibodies (red) show no labeling
without permeabilization. Antibody labeling
was enabled by permeabilization with 0.5%
acetone (see Experimental Procedures), indi-
cating that both termini are on the cyto-
plasmic face of the membrane.
(C) Surface labeling experiments with guinea
pig sigma receptor (lanes 1, 3, 5, and 7) and
rat sigma receptor (lanes 2, 4, 6, and 8) ex-
pressed in oocytes using Sulfo-NHS-SS-bio-
tin. Labeling was tested in unpermeabilized
cells (lanes 1, 2, 7, and 8), permeabilized cells
(lanes 3 and 4), and total membrane lysates
(lanes 5 and 6). Controls (lanes 7 and 8) were
conducted on oocytes labeled as in lanes 1–4
but without strepavidin-coated beads. Kv1.4
was also surface labeled both alone (lane 9) and coexpressed with sigma receptor (lane 10). The similar amount of protein recovered in the
two experiments indicates that sigma receptor expression does not significantly alter surface expression of Kv1.4. As a control for the surface
specificity of Sulfo-NHS-SS-biotin, labeling of GFP was seen in permeabilized cells (lane 12), but not in either unpermeabilized cells (lane 11)
or in samples processed without strepavidin-coated beads (lane 13, unpermeabilized; lane 14, permeabilized).
the excitation wavelength was set for GFP. However, lized strepavidin. In unpermeabilized oocytes express-
ing the guinea pig sigma receptor, quantitative labelingwhen the excitation wavelength was set for Texas red,
antibody-treated oocytes expressing N-GFP-Sigma or was obtained (lane 1, Figure 6C); the amount of protein
recovered was not significantly increased by permeabili-C-GFP-Sigma revealed no fluorescence if they had not
been permeabilized previously (Figure 6B). In oocytes zation (lane 3, Figure 6C). Similar quantities of sigma
receptor were recovered from total oocyte membraneexpressing either fusion protein, permeabilization with
0.5% acetone (see Experimental Procedures) permitted lysates (lane 5, Figure 6C). These results indicate that
most of the guinea pig sigma receptor is in the oocyteanti-GFP antibodies to bind, and red fluorescence could
then be seen (Figure 6B). Control oocytes (uninjected plasma membrane, as suggested by the distribution of
fluorescence (Figures 5A and 5B).or expressing wild-type sigma receptor) showed only a
low level of autofluorescence with the GFP or Texas In contrast to the results obtained with the guinea pig
sigma receptor, Sulfo-NHS-SS-biotin labeled only aboutred excitation wavelength in both permeabilized and
unpermeabilized oocytes. Thus, both the N and C termini 20% of the rat sigma receptor in unpermeabilized oo-
cytes (lane 2, Figure 6C). Permeabilization resulted inare inaccessible from the outside of the cell. The sigma
receptor, therefore, is likely to have two TM segments, quantitative labeling, as compared to sigma receptor in
membrane lysates (compare lanes 4 and 6 of Figure 6C).with both termini at the cytoplasmic face of the mem-
brane. The resistance of the rat sigma receptor to labeling prior
to permeabilization suggests that this receptor does notTo evaluate the surface exposure of proteins in oo-
cytes, we employed the surface biotinylation reagent present amino groups at the extracellular face of the
membrane. In fact, the deduced amino acid sequenceSulfo-NHS-SS-biotin. This reagent forms a covalent bio-
tin conjugate with primary amino groups and reacts of the rat sigma receptor contains no lysines between
the two putative transmembrane segments indicatedweakly with arginine guanido groups as well. After treat-
ing oocytes, labeled protein was isolated with immobi- from the homology plot (Figure 6A; see Figure 8 for a
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structural model). The guinea pig receptor has only
one lysine in this loop, at position 60. This residue is
an arginine in the rat sigma receptor. The weak labeling
of the rat sigma receptor can be explained by the
slow reaction of Sulfo-NHS-SS-biotin with arginine, five
of which are present in the putative extracellular loop of
the rat sequence. There are two other potential sites of
biotinylation in the rat sigma receptor: the terminal
amino group and lysine 142. Since these sites are lo-
cated in the N and C termini, respectively, the weak
labeling in unpermeabilized cells indicates that both ter-
mini are at the cytoplasmic face of the membrane, cor-
roborating the results obtained with sigma receptor-
GFP fusion proteins.
Surface labeling of Kv1.4 was also achieved, consis-
tent with its membrane location. Expressed GFP was
not labeled (lane 11, Figure 6C) unless the cells were
permeabilized (lane 12), and this is consistent with a
cytoplasmic location. Importantly, surface labeling of
Kv1.4 was not significantly different when the sigma
receptor was also expressed (compare lanes 9 and 10
in Figure 6C). This indicates that sigma receptor expres-
sion does not alter the level of expression of Kv1.4.
Sigma Receptor-Kv1.4 Association
Physiological studies had indicated that sigma receptor
ligands modulate ion channels without assistance from
other proteins commonly involved in signal transduction
(Lupardus et al., 2000). Results presented above indi-
cated functional interactions in the absence of ligand
(Figure 3). These results could be explained by a direct
physical interaction between sigma receptors and chan-
nels. To investigate this possibility, immunoprecipitation
Figure 7. Coimmunoprecipitation of Sigma Receptors and Kv1.4experiments were performed to detect the association.
ChannelsMembrane lysates were prepared from the posterior
(A) Membrane lysates were prepared from rat posterior pituitary,pituitary of rats. Duplicate samples were processed with
immunoprecipitated with anti-Kv1.4 antibody, and resolved withor without mouse anti-Kv1.4 antibody, as described in
SDS-PAGE. Immunoprecipitated samples were run on duplicateExperimental Procedures. Samples were then resolved
gels and the blots probed with either anti-sigma receptor or anti-
with SDS-PAGE and probed with rabbit antibodies Kv1.4 antibodies, as labeled. Total membrane preparations were
against Kv1.4 or sigma receptor. Bands were visualized run in lanes 1 and 3, and the eluates from the coimmunoprecipi-
with an HRP-conjugated antibody and enhanced chemi- tations were run in lanes 2 and 4.
(B) Membrane lysates were prepared from Xenopus oocytes ex-luminescence, as described in Experimental Proce-
pressing Kv1.4 (lanes 5 and 6), sigma receptors (lanes 3 and 4), anddures.
both Kv1.4 and sigma receptors (lanes 1, 2, 7, and 8). The lysatesProbing the gels with antibodies against Kv1.4 re-
were immunoprecipitated with anti-Kv1.4 antibody and resolved
vealed distinct band(s) near 87 kDa in samples immuno- with SDS-PAGE. Immunoprecipitated samples were run on dupli-
precipitated with anti-Kv1.4 antibodies (Figure 7A). cate gels, and blots were probed with either anti-sigma receptor or
Probing with anti-Kv1.4 antibodies failed to detect anti-Kv1.4 antibodies, as labeled. Total membrane lysates (lanes 1,
3, 5, and 7) and the coimmunoprecipitated eluates (lanes 2, 4, 6,bands in control samples processed without the Kv1.4
and 8) are shown. The oocyte eluates were concentrated 4-fold,immunoprecipitating antibody.
compared to the total membrane lysates. Control samples withoutProbing with antibodies against the sigma receptor
an immunoprecipitation antibody are included (lane 8).
revealed a band at 25 kDa in the sample immunopre- (C) Sigma receptors were coimmunoprecipitated with Kv1.4 chan-
cipitated with antibodies against Kv1.4 (Figure 7A). No nels. Again, membrane lysates were prepared and coimmunopreci-
sigma receptor bands were observed in the control sam- pitation was attempted with an anti c-myc antibody. The samples,
both total membrane lysates (lanes 1 and 3) and eluates (lanes 2ple prepared without the anti-Kv1.4 immunoprecipitat-
and 4), were separated on duplicate SDS-PAGE gels, blotted, anding antibody. Thus, immunoprecipitation of Kv1.4 from
probed with anti-sigma receptor or anti-c-myc antibodies, as la-rat posterior pituitary lysate pulls down the sigma recep-
beled. Molecular weight markers are shown to the right of all blots.
tor. The molecular mass of the sigma receptor band is
indistinguishable from the deduced molecular weight of
25.3 kDa. The sequence contains no putative N-glyco- A similar experiment was carried out in oocytes ex-
pressing Kv1.4 and sigma receptor (see Experimentalsylation sites (Kekuda et al., 1996), and the similarity
between the deduced and apparent molecular weights Procedures). Here, Kv1.4 ran in a single band with a
molecular mass very close to the predicted value (Figuresuggests that the sigma receptor is not posttransla-
tionally modified by the addition of bulky moieties. 7B). As with the posterior pituitary, samples immunopre-
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cipitated with anti-Kv1.4 antibodies and control samples nerve or oocytes. Additional support for this hypothesis
derives from the finding that the sigma receptor alterswere divided into duplicate, processed, and resolved
channel function in the absence of ligand. The picturewith SDS-PAGE. Western blots revealed the sigma re-
that emerges from these studies is that the sigma recep-ceptor at 25 kDa in the sample immunoprecipitated
tor associates with Kv1.4 channels, and within this com-with anti-Kv1.4 antibody, but not in the control sample
plex, functionally relevant interactions take place be-(Figure 7B). The interaction between Kv1.4 and sigma
tween the two proteins. These interactions take on tworeceptor can thus be detected both in posterior pituitary
forms. In the absence of a sigma receptor ligand, thenerve terminals and in the oocyte heterologous expres-
sigma receptor accelerates voltage-dependent channelsion system.
inactivation by a factor of 3. In the presence of ligand,Based on the intensities of these bands, we estimate
the interaction between the sigma receptor and Kv1.4that our antibodies against Kv1.4 precipitated 92% of
reduces peak current flow by 70%. The ligand-inde-the Kv1.4 protein in oocytes and coprecipitated 26%
pendent interactions also reduce current amplitudeof the total sigma receptor. In the posterior pituitary,
through Kv1.4 channels, and since Sulfo-NHS-SS-biotinantibodies against Kv1.4 precipitated the same percent-
labeling indicated that Kv1.4 surface expression wasage of Kv1.4 protein (92%) but only coprecipitated 8%
not reduced by coexpression with sigma receptor (lanesof the total sigma receptor. The intensity of the Kv1.4
9 and 10, Figure 6C), it is likely that the lower currentbands was12% and 16% of the intensity of the sigma
amplitude is a consequence of the interaction betweenreceptor bands in gels of oocyte and pituitary membrane
these proteins.lysates, respectively. Thus, the sigma receptor is in 6-
The functional changes brought about by coexpres-to 8-fold excess over Kv1.4 in the two systems. This is
sion and the demonstration that sigma receptors arelikely to be one factor in the incomplete coprecipitation
precipitated by antibodies against Kv1.4 indicates thatof sigma receptors with Kv1.4. However, the lower per-
these two proteins are part of a complex. Whether thecentage of sigma receptor coprecipitation with Kv1.4 in
two proteins adhere through a direct interaction orpituitary versus oocytes (8% and 26%) probably reflects
through interactions with additional proteins cannot bethe presence of additional ion channel targets in the
answered at present. In Xenopus oocytes, the coprecipi-pituitary, such as the BK channel (Wilke et al., 1999a).
tation of the two exogenous proteins might be taken asThe immunoprecipitated Kv1.4 from posterior pitu-
evidence that the interaction does not require additionalitary has a higher molecular mass (87 kDa) than that
proteins. However, it is possible that homologous Xeno-expressed in oocytes (73 kDa). This is thought to be
pus proteins substitute for additional signal transducingdue to differences in glycosylation (Shi and Trimmer,
proteins. This possibility is consistent with the finding1999). In some blots of Kv1.4 from the posterior pituitary,
that endogenous Xenopus sigma receptors support lowmultiple bands are observed at around 87 kDa, and this
levels of channel modulation without exogenous sigmaprobably also reflects differences in glycosylation (data
receptor (Figures 1 and 2). The fact that the Xenopusnot shown). The sigma receptor has a molecular mass
sigma receptor can modulate rat channels indicates thatof 25 kDa in both posterior pituitary and Xenopus oo-
other Xenopus proteins could also substitute for rodentcytes.
proteins in this transduction process. The involvementTo evaluate the specificity of sigma receptor-Kv1.4
of additional proteins in the stabilization of the sigmacoimmunoprecipitation, we tested the GIRK1 (G protein-
receptor-K channel complex is suggested by the re-coupled receptor activated channel) channel for its abil-
cent report of a ternary complex between sigma recep-ity to coimmunoprecipitate with the sigma receptor in
tors, IP3 receptors, and ankyrin (Hayashi and Su, 2001),Xenopus oocytes. GIRK1 expression induced small
but this complex was observed in the endoplasmic retic-K currents in oocytes, and these currents were not
ulum and much of our data suggests that the sigmamodulated by sigma receptor ligands, either in the pres-
receptor-Kv1.4 complex resides in the plasma mem-
ence or absence of sigma receptors (data not shown).
brane. The close agreement between the channel inacti-
In oocytes expressing the sigma receptor and GIRK1,
vation rate of the expressed sigma receptor-Kv1.4 com-
the sigma receptor was not coprecipitated by antibodies plex and the A current of posterior pituitary nerve
against the myc tag of GIRK1 (Figure 7C). terminals (Figure 3) would require that additional Xeno-
pus ersatz proteins have exactly the same functional
Discussion activity as the rat protein.
It is likely that the functional interaction between
The results presented here support the hypothesis that sigma receptors and Kv1.4 channels depends on con-
sigma receptor signal transduction is mediated by a tacts between these two proteins. The original analysis
protein-protein interaction. This form of transduction of the sigma receptor failed to turn up sequences that
was proposed recently based on negative results with might mediate contacts with other proteins (Hanner et
reagents and manipulations that eliminate or alter G al., 1996; Kekuda et al., 1996; Seth et al., 1997). We
protein function and protein phosphorylation (Lupardus repeated this analysis using the computer programs
et al., 2000). The present study supports this hypothesis ProfileScan and Smart, using the most current sequence
with two additional forms of evidence. (1) Reconstitution data, and confirmed the absence of recognizable pro-
of sigma receptor-mediated responses in oocytes was tein-protein interaction motifs, such as SH3, PDZ, or
achieved with the sigma receptor and Kv1.4 or Kv1.5 WW motifs. Since ligand binding to sigma receptors
channels as the only two heterologously expressed pro- alters K channel function, the contacts between these
teins. (2) The sigma receptor was precipitated by anti- two proteins must be malleable. The domains responsi-
ble for these interactions have yet to be identified, butbodies against the Kv1.4 channel from extracts of either
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merases, and  subunits are homologous with aldo-
keto reductases. Indeed, consideration of its cofactor
binding site prompted the suggestion that  subunits
(Gulbis et al., 1999), like sigma receptors, might be sensi-
tive to ligands or chemical signals. The sensitivity to O2
conferred by a  subunit was offered as a case in point
(Perez-Garcia et al., 1999). The  subunits associated
with members of the Kv1 family are peripheral mem-
brane proteins with no putative TM segments. The struc-
turally distinct  subunit of the Ca2-activated K chan-
nel Slo has two putative TM segments and a proposed
topology (Knaus et al., 1994) very similar to that pro-
posed here for sigma receptors (Figure 8). Slo alters
channel activity in a manner quite different from that
described here (Dworetzky et al., 1996). However, Dwor-
etzky et al. (1996) also noted that Slomodifies the drug
sensitivity of the channel, and the sigma receptor clearly
has that capability. The inactivation kinetics of the sigma
receptor-Kv1.4 complex (Figure 3) may indicate that this
complex produces the A current of nerve terminals. Con-
sidering the broad properties and structures of proteins
designated as  subunits of voltage-gated channels, it
may be worth considering sigma receptors as candi-
dates for this grouping.
Figure 8. A Structural Model for the Sigma Receptor The idea of a sigma receptor-K channel complex
This model contains two transmembrane segments in the regions casts some earlier puzzling pharmacological results in
indicated by the TM homology plot (Figure 6A). The N and C termini an interesting light. In rodent posterior pituitary, the
are shown on the intracellular side of the membrane, as indicated
sigma receptor modulates two distinct K channelsby the inaccessibility of GFP tags (Figure 6). The two lysines in the
(Wilke et al., 1999a). In mouse, one particular ligand,guinea pig sigma receptor are indicated by closed diamonds. In the
U101958, only modulated the function of a slowly inacti-rat sigma receptor, residue 60 is arginine, so the only primary amino
groups are lysine 142 and the terminal amino group. Their intracellu- vating Ca2-activated K channel and failed to modulate
lar location in this model is consistent with poor biotin labeling prior the A current. Another sigma receptor ligand, PPHT,
to permeabilization and efficient labeling thereafter. modulated both channels. In rat, several different sigma
receptor ligands modulated both channels with equal
efficacy (Wilke et al., 1999a), but the sigma receptorthe present studies on receptor topology suggest a
ligand NE-100 only inhibited the Ca2-activated K
structural model of the sigma receptor with domains
channel (M.J., unpublished data). These findings recall
that can be probed for interactions with channels (Figure
the differential coupling of PACAP receptors to different
8). Based on lack of antibody access to GFP labels at
effectors when different agonists were used to activate
the two termini, surface labeling experiments with Sulfo- the receptor (Spengler et al., 1993). A three-state alloste-
NHS-SS-biotin, and analysis of homology with TM seg- ric mechanism was invoked to explain this behavior (Leff
ments, we propose that the sigma receptor has two TM et al., 1997). However, if the receptor and channel form
segments, a 50 amino acid extracellular loop and a a complex, then the channel could contribute to the
125 amino acid intracellular C terminus. The C termi- drug binding site and allow different channels to be
nus contains the region homologous with fungal sterol preferentially modulated by different drugs. Sigma re-
isomerase. The N terminus is also intracellular but is ceptors exhibit extremely promiscuous binding activity.
relatively short (10 amino acids). This domain map of Because of this, they have been confused with phency-
the sigma receptor should serve as a useful guide for clidine receptors, opioid receptors, and dopamine re-
more detailed studies of the interaction between sigma ceptors (de Costa and He, 1994). If the binding activity
receptors and their regulatory targets. of this molecule depends on the presence and identity
The finding that the sigma receptor forms a stable of an associated channel, this could account for some of
complex with Kv1.4 channels and that sigma receptors the confusion in the literature.
can modify channel function calls to mind the  subunits Recognition of the importance of protein-protein inter-
of voltage-gated channels (Adelman, 1995; Pongs et al., actions in membrane signaling has grown in recent
1999). Although the sigma receptor has no sequence years. The  subunits discussed above provide many
homology with these proteins, there are some interest- examples. Another example is the receptor-activity-
ing parallels. Some of the subunits specifically acceler- modifying proteins, which modify the function of the
ate inactivation (Rettig et al., 1994), as did the sigma calcitonin receptor-like receptor (McLatchie et al., 1998).
receptor (Figure 3). However, subunits accelerate inac- The GABAA receptor and D5 dopamine receptors form
tivation with an inactivating N-terminal ball domain, a a complex with reciprocal functional interactions (Liu et
motif absent from the sigma receptor sequence. Another al., 2000). The present findings indicate that the sigma
interesting parallel is that both sigma receptors and  receptor also performs a membrane signaling operation
subunits show sequence homology with enzymes. based on protein-protein interactions and possibly be-
longs to an extended family of auxiliary  subunits ofSigma receptors are homologous with fungal sterol iso-
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Confocal Fluorescence Microscopyvoltage-gated channels. Determining the relative impor-
Oocytes expressing GFP-sigma receptor fusion proteins, GFP-tance of the ligand-dependent and ligand-independent
Kv1.4 fusion proteins, or GFP were viewed with a Bio-Rad MRCforms of ion channel modulation by sigma receptors
1024 confocal laser scanning microscope using 20	 or 4	 objec-
presents an interesting new direction in the study of the tives. GFP and Texas red fluorescence were selected with the pre-
role of protein-protein interactions in membrane sig- scribed optical methods of this microscope. All images were re-
corded at the same settings of laser power and photo-multipliernaling.
sensitivity (30% laser, no low signal). Images were processed with
Adobe Photoshop (ADOBE Systems, Mountain View, CA) with identi-Experimental Procedures
cal values for contrast and brightness.
Oocyte Expression
Oocytes were removed from anesthetized frogs (Xenopus laevis, Immunohistochemistry of GFP-Sigma Receptor
Fusion ProteinsNasco) through a small abdominal incision, according to procedures
approved by the University of Wisconsin Research Animals Re- Oocytes expressing N-GFP-Sigma and C-GFP-Sigma were perme-
abilized by treatment for 30 min with 0.5% acetone in ND96. Perme-source Center and the NIH. The follicular membranes were removed
following collagenase treatment (Collagenase B, Boehringer Mann- abilized or unpermeabilized oocytes were washed five times in ND96
and then incubated in mouse anti-GFP antibody (Molecular Probes,heim) and, in some cases, following osmotic shock (Pajor et al.,
1992). Eugene, OR) for 1 hr in ND96, with 1% BSA at 18
C. The oocytes
were then washed five times in ND96 and incubated in donkey anti-mRNA was synthesized from a T7 promoter using the mMESSAGE
mMACHINE kit (Ambion, Austin, TX). Sigma receptor antisense RNA mouse IgG Texas red conjugate (Jackson ImmunoResearch) for 1 hr
in ND96 with 1% BSA at 18
C. The oocytes were washed five morewas generated using a pGH19 vector and synthesized from an SP6
promoter using the same kit. RNA was diluted in sterile water to times in ND96, after which Texas red fluorescence was visualized
by confocal microscopy.different ratios to give upon expression an optimal 5–50 A outward
current for depolarizing steps to 40 mV. Oocytes were cultured at
18
C in ND96 (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, Immunoprecipitation
5 mM HEPES, and 10g/ml gentamicin [pH 7.4]). The clone for Kv1.4 The posterior pituitary gland was removed from ten 2-month-old
was provided by G.N. Tseng of Virginia Commonwealth University rats and homogenized at 4
C with a 10 ml dounce homogenizer in
(Tseng-Crank et al., 1990). The clone for Kv1.5 was provided by L. 200 l 1% Triton X-100 in IP buffer (100 mM NaCl, 10 mM Tris, 5
Kaczmarek of Yale University (Pragnell et al., 1990). The clone for mM EDTA [pH 7.4]) with a proteinase inhibitor cocktail (CytoSignal,
the rat sigma receptor was provided by V. Ganapathy of the Medical Irvine, CA). The homogenate was spun twice at 13,000 rpm for 15
College of Georgia (Kekuda et al., 1996). The clone for the guinea pig min at 4
C in microtubes, and the supernatant was removed and
sigma receptor was provided by A. Ruoho. Except for the indicated split into two 100 l aliquots. Mouse anti-Kv1.4 antibody (1 g)
biotinylation experiments presented in Figure 6, all results reported (Upstate Biotechnology, Lake Placid, NY) was added to one aliquot,
here were obtained with the rat sigma receptor clone. The clone for but not to the other. Samples were incubated for 18 hr at 4
C with
GIRK1 (Kir3.1) was provided by H.H. Van Tol of University of Toronto, gentle rocking. The immunoprecipitation was processed using an
and a c-myc tag was attached to the C terminus by PCR. IMMUNOcatcher kit (CytoSignal, Irvine, CA). Eluates and total mem-
brane preparations were loaded on duplicate 10% SDS-PAGE gels
and subsequently blotted to a PVDF membrane. Following blockingCurrent Recording and Data Analysis
Current was recorded using a two-electrode voltage clamp (Model in 4% BSA in IP buffer with 0.01% Tween 20, each blot was incu-
bated with a rabbit anti-Kv1.4 antibody (Alomone Labs, Jerusalem)725A, Warner Instruments, Hamden CT) and pClamp 7.0 software
(Axon Instruments, Foster City, CA). Oocytes were impaled with two or a rabbit anti-sigma receptor antibody (Yamamoto et al., 1999).
A detection system, consisting of an anti-rabbit IgG horseradishglass microelectrodes filled with 2 M KCl and having resistances of
0.5–1 M. Recordings were performed at room temperature (25
C) peroxidase conjugate (Jackson ImmunoResearch, West Grove, PA)
and an ECL detection kit (Amersham Pharmacia, Piscataway, NJ)with oocytes bathing in a solution consisting of: 93 mM NaCl, 5 mM
KCl, 1 mM MgCl2, 0.3 mM CaCl2, and 5 mM HEPES (pH 7.4). Drugs was used to visualize immunoprecipitated proteins, followed by
detection on XOMAT film or detection and quantification using aused in these experiments were obtained from Sigma (St. Louis,
MO). Compounds were dissolved in bathing solution and either su- LUMI-Imager detection system (Roche). Immunoprecipitated bands
were compared to protein markers of known molecular size run inperfused onto the preparation at a rate of 2–4 ml/min by a gravity-
feed system or added directly to the bathing solution by pipette parallel on the SDS-PAGE gel (Amersham rainbow markers).
Membrane lysates were prepared from Xenopus oocytes 4 daysinjection. Prior to adding drugs, K current was recorded at 15 s
intervals for 1–3 min to obtain a stable baseline. Current was also after injection with Kv1.4 and Sigma receptor mRNA (Connor et al.,
1998). The lysates were processed by the same procedure de-recorded after drug removal to demonstrate reversibility. The highly
lipophilic drug ditolyl-guanidine (DTG) was first dissolved in DMSO scribed above for the posterior pituitary. The immunoprecipitated
proteins were separated, blotted, and detected as described above.and then diluted into bathing solution. PClamp and Origin 5.0 (Micro-
cal Software Inc., MA) were used for data analysis and generating As a control, coprecipitation experiments were carried out with
GIRK1 containing a c-myc tag and using an anti c-myc antibody forplots.
K current was recorded from nerve terminals of the posterior immunoprecipitation and Western detection.
pituitary by techniques described previously (Lupardus et al., 2000;
Wilke et al., 1999a). The time constant for inactivation of the A Biotin Labeling
current was taken as the fast component of a double exponential Oocytes expressing guinea pig sigma receptor, rat sigma receptor,
fit (Bielefeldt et al., 1992). Kv1.4, or GFP (4 days postinjection) were incubated for 30 min in
either ND96 or ND96  0.5% acetone (permeabilization agent) at
16
C, followed by three washes in ND96. The oocytes were subse-Sigma-GFP Fusion Constructs
Sigma receptor-GFP fusion constructs were prepared by PCR, with quently incubated in 10 mM EZ link Sulfo-NHS-SS-biotin (Pierce
Biochemicals) in ND96 for 10 min at 16
C, followed by three washessix extra bases between the sigma receptor and the GFP sequences
(encoding glu-phe). GFP was fused either to the N terminus of the in IP buffer to neutralize the surface label. Ten oocytes each were
suspended in 400 l of fresh IP buffer proteinase inhibitor cocktailsigma receptor (N-GFP-Sigma) or the C terminus (C-GFP-Sigma)
and subcloned into the pGH19 Xenopus oocyte RNA transcription (used in immunoprecipitation), and membrane lysates were pre-
pared as described above. The preparations were divided in twovector. GFP was fused to the C terminus of Kv1.4 by the same
procedure. Constructs were confirmed by DNA sequencing and and either 20 l of strepavidin immobilized to beaded agarose
(Sigma) was added or agarose beads alone were added, and therestriction enzyme digestion. These fusion proteins were expressed
by procedures described above, and the oocytes were used for preparations were incubated at 4
C for 4 hr with gentle rocking.
These preparations were subsequently processed using IMMUNO-experiments 4 days after injection.
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catcher columns (CytoSignal) and washed once with both IP buffer tion of the site of incorporation and implications for channel topol-
ogy. J. Biol. Chem. 269, 23336–23341.and IP buffer with 1% SDS. Subsequent elution of the biotin-labeled
proteins was achieved by incubation in IP buffer with 2% mercapto- Leff, P., Scaramellini, C., Law, C., and McKechnie, K. (1997). A three-
ethanol heated to 80
C for 10 min. The preparations were separated state receptor model of agonist action. Trends Pharmacol. Sci. 18,
on 12% SDS-PAGE gels, Western blotted, and probed with anti- 355–362.
sigma receptor antibody, anti-Kv1.4 antibody, or an anti-GFP anti-
Liu, F., Wan, Q., Pristupa, Z.B., Yu, X.-M., Wang, Y.T., and Niznik,body, as described above.
H.B. (2000). Direct protein-protein coupling enables cross-talk be-
tween dopamine D5 and -aminobutyric acid A receptors. Nature
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